News

BioArctic AB (publ) announced that BioArctic and its partner AbbVie have received U.S. Federal Trade Commission (FTC) clearance to license BioArctic's alpha-synuclein antibody portfolio…
Read More...

Innovent Biologics, Inc. (Innovent)  and Incyte announced that the companies, through their respective subsidiaries, have entered into a strategic collaboration agreement for three…
Read More...

AMAG Pharmaceuticals announced it has entered into a definitive agreement to acquire Perosphere Pharmaceuticals Inc., a private biopharmaceutical company. Through this acquisition, AMAG…
Read More...

The Global Antibiotic Research and Development Partnership (GARDP), Eisai Co., Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement for GARDP to access and screen…
Read More...

Novartis announced that the European Commission (EC) has approved Xolair (omalizumab) prefilled syringe (PFS) for self-administration, allowing patients with severe allergic asthma…
Read More...

Dragonfly Therapeutics announced it has licensed two TriNKET immunotherapy drug candidates to Celgene Corporation and its affiliates for $12m each plus prospective milestones and…
Read More...

Pharmaceutical Product Development, LLC (PPD) is adding significant therapeutic expertise in cardiovascular disease, critical care, endocrinology, metabolism and diabetes to further…
Read More...

Avacta Group plc and LG Chem Life Sciences announced a multi-target collaboration and development agreement. The agreement provides LG Chem with the exclusive rights to develop and…
Read More...

Berkeley Lights, Inc. and Novo Nordisk announced that Novo Nordisk has purchased the Beacon® Optofluidic platform to accelerate workflows in cell line development and to use the…
Read More...

Eli Lilly and Company and AC Immune SA announced that the two companies have signed a license and collaboration agreement to research and develop tau aggregation inhibitor small…
Read More...

X-Chem, Inc., a privately held biotechnology company applying its innovative drug discovery platform to the generation of novel small molecule therapeutics, announced a drug discovery…
Read More...

Black Diamond Therapeutics, a biotechnology company developing a new type of precision medicine for cancer, came out of stealth mode today with a $20 million Series A financing…
Read More...

Schrödinger and TB Alliance announced a three-year research collaboration to speed the development of next-generation tuberculosis (TB) treatments by leveraging Schrödinger’s advanced…
Read More...

InveniAI Corporation announced that it has entered a collaboration agreement with Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin) to harness the power of AI and ML for drug discovery.…
Read More...

Cambrex Corporation announced that it is investing $1 million at its High Point, NC site to fit out 1,300 sq. ft. of analytical laboratory space and plans to hire 9 chemical research…
Read More...

Amgen announced a novel multi-year collaboration with Magellan Rx Management, the pharmacy benefit management division of Magellan Health, that will leverage each company's capabilities…
Read More...

Vect-Horus announced the signing of a research collaboration agreement with Janssen Pharmaceuticals, Inc. one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The goal…
Read More...

Alnylam Pharmaceuticals announced that it has resolved all litigation worldwide with Silence Therapeutics. The settlement allows Alnylam to avoid the costs and distraction associated…
Read More...

SGS announced that it is investing €3.5 million to undertake a two-phase expansion project at its laboratory in Poitiers, France, to implement a 50% increase in bioanalytical…
Read More...

WuXi AppTec announces the expansion of its facilities in San Diego, California. WuXi AppTec's newly expanded facility will establish a center of excellence in screening, discovery…
Read More...